Ladies and gentlemen, welcome to the Sartorius and Sartorius Stedim Biotech Conference Call ... our manufacturing presence in Yauco. I think just a minute ago, Rene was talking about the bandwidth ...

Sartorius Stedim Biotech SA (DIM), with a market capitalization of $135.93 million, reported robust earnings for the first quarter of 2025, exceeding analyst expectations with an earnings per share ...

Sartorius Stedim Biotech SA (DIM), with a market capitalization of $135.93 million, reported robust earnings for the first quarter of 2025, exceeding analyst expectations with an earnings per ...

Sales revenue at 745 million euros, up 10.4 percent in constant currencies 1 (reported: 11.7 percent) Sartorius Stedim Biotech, a leading partner to the biopharmaceutical industry, started the ...

Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: Information on Document Availability 17-Feb-2025 / 10:56 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group.

The shares of Sartorius Stedim Biotech S.A. are quoted on the Euronext Paris. The company has a strong global reach with manufacturing and R&D sites as well as sales entities in Europe, North America, ...

CapEx Ratio: 12.2% at year-end, down from 17.1% in the previous year. Net Debt to EBITDA Ratio: 2.8% for Sartorius Stedim Biotech Group. Sartorius Stedim Biotech SA (SDMHF) achieved its reverse ...

In a challenging environment, Sartorius Stedim Biotech, a leading provider of innovative technologies for the manufacture of biologics, closed the fiscal year with a solid performance. With sales ...

Jan 28 (Reuters) - Shares in Sartorius (SATG.DE), opens new tab jumped 15.6% on Tuesday after the Franco-German lab supplies maker's preliminary annual results beat expectations and despite a ...

=----- Sartorius Stedim Biotech S.A. - 13400 Aubagne, France DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Article L 233-8-II of the Code of commerce ...

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts. This state-of-the-art facility is designed ...